| 1. | Merial limited is a joint venture between merck & co . , inc . and sanofi - aventis
梅里亚是美国默克与欧洲赛诺菲-安万特集团属下的合资公司。 |
| 2. | Today , sanofi pasteur reinvests some 17 percent of its revenues into research and development
今天，赛诺菲巴斯德投入公司收入的17 %用于疫苗的研发。 |
| 3. | The experimental accine , made by sanofi - pasteur , protected only 45 percent of the 91 people on whom it was tested in a hasty clinical trial
该疫苗由赛诺菲巴斯德公司生产，在一个仓促的临床试验中，该疫苗只能保护45 %的受试者（共91人） 。 |
| 4. | In that case , dankong has established a long term business relations with basf , dystar , sanofi , merck , hoechst , chemo and other top companies
以及安全生产许可证废水废气达标排放和清洁生产审核验收，实现了企业效益社会效益生态效益的三统一。 |
| 5. | Sanofi , the world ' s third - largest drugmaker , already has a significant commercial presence in china and is conducting many clinical trials in the country
赛诺菲，作为世界第三大制药公司，在中国已经有一个重要的商业地位，并正在进行多项临床试验 |
| 6. | In a presentation to the panel today , sanofi officials argued that the drug ' s risks could be managed by screening out patients with psychiatric problems
今天赛诺菲公司人员向专家委员会做陈述时，辩称可通过筛除精神病疾患的病人而得以控制该药物的风险。 |
| 7. | Sanofi ' s move reflects the rapidly growing importance of china in the pharmaceutical landscape - - as a centre for basic research , clinical trials , production and future sales
赛诺菲的举动反映了，中国作为制药领域的基础研究，临床试验，生产和销售中心,其重要性在不断增加。 |
| 8. | Any opinions , conclusions , advice or statements contained in this email should not be relied upon unless they are confirmed in writing by contracts , agreements or statements signed by sanofi - aventis
对于本电子邮件中包含的观点、结论、建议或陈述，除非已经赛诺菲安万特书面签署合同、协议或声明予以确认，不应被作为任何行为的依据。 |
| 9. | As part of its continuing effort to extend and improve its research programme , and within the context of its development in china over the last ten years , sanofi pasteur is currently seeking new collaborative partners in your country
为不断拓展和改进研究工作，并秉承其在中国的一贯发展策略，赛诺菲巴斯德正在中国寻找新的研发合作伙伴。 |
| 10. | Paris / london ( reuters ) - sanofi - aventis has signed a research collaboration agreement with a chinese institute in the cancer stem - cell field , becoming the latest big drugmaker to tap into china ' s growing life science skills
巴黎/伦敦（路透社） -赛诺菲安万特与中国一家研究所在癌症干细胞领域签署了一项研究合作协议，它将是进入不断成长的中国生命科学领域的最新一家大型制药公司。 |
